Everything is Bigger in Texas...Including Medicaid

Medicaid enrollment has climbed by 80,000 in Texas despite the state opting out of Medicaid expansion.

Jul 20, 2014 at 1:00PM

Despite choosing not to embrace Medicaid expansion, more than 80,000 Texans have enrolled in the government program thanks to increased awareness following the launch of Obamacare exchanges launch last fall.

The jump in enrollment presents a problem for states like Texas that opted against bumping up eligibility because it increases the amount the state will spend on the program, but it's good news for Centene (NYSE:CNC) and Molina (NYSE:MOH), two companies that help run the state's Medicaid program.


Source: Governor of Texas Flickr

First, a bit of background
Initially, the Affordable Care Act's Medicaid expansion provision effectively increased eligibility to 138% of the Federal poverty level nationwide, or roughly $33,000 for a family of four. For those that were found newly eligible, the Federal government agreed to pay 100% of the cost of care initially and no less than 90% of costs in the future, with the states picking up the rest.

However, the Supreme Court gave states the option not to expand their program in 2012 and as a result; just 26 states opted to increase coverage.

Even though a significant number of states didn't expand (including Texas), Medicaid has still proven widely successful at signing up new members nationwide.

According to the Centers for Medicare and Medicaid Services, more than 6 million people have enrolled in Medicaid since last summer, including 725,000 members in non-expansion states like Texas. That means that private Medicaid insurers that are running plans in states that didn't expand Medicaid are still getting a windfall.


Source: Centene Corp.

Surging demand
Centene's biggest markets opted out of Medicaid expansion, including Texas, where Centene serves 900,000 members and Florida, where Centene serves 230,000 members.

But even though so much of Centene's business comes from these non-expansion states, Centene revenue is jumping.

The company serves nearly 2.9 million people who participate in government funded programs like Medicaid and CHIP, and a 13% jump in membership in the first quarter resulted in Centene's sales growing by a third to $3.46 billion in the first quarter.

Molina Healthcare's Medicaid business is humming too. Molina serves 2.1 million members including 246,000 in Texas, but it's less reliant on non-expansion states for growth. That's because Molina does a lot of business in California, a state that embraced expansion and has seen Medicaid applications soar.

In the first quarter, California accounted for 47,000 of Molina's 133,000 new Medicaid members and those new members helped Molina's revenue climb 21% to $2.1 billion.

Although Medicaid insurers like Centene and Molina have smaller margins than larger, more diversified insurers that serve commercial customers, rising revenue has both companies expecting to post significant earnings growth this year. Centene expects its EPS will reach between $3.60 and $3.90 this year, up from $2.87 last year, and Molina is guiding investors to expect EPS of between $4 and $4.50 this year, up from $3.13 in 2013.

Fool-worthy final thoughts
Kaiser estimates that as many as one million Medicaid applications nationwide have yet to be processed, so there's likely to be additional membership growth in the third quarter too.

But growth over the coming year won't just come from expansion states. Kaiser reports that roughly 875,000 Texans qualify for Medicaid but haven't yet signed up for the program.

Centene will release its second quarter results on July 22nd and Molina will update investors with its second quarter numbers on July 30th, so investors won't have to wait long to find out whether rising membership drove profits again last quarter, but given the numbers we're seeing out of states like Texas, it wouldn't surprise me if both companies posted solid results.

Leaked: This coming blockbuster will revolutionize health care way beyond Texas
The best biotech investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not just how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool's new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.

Todd Campbell owns shares of Molina Healthcare and Centene Corp. Todd owns E.B. Capital Markets, LLC. E.B. Capital's clients may or may not have positions in the companies mentioned. Todd owns Gundalow Advisors, LLC. Gundalow's clients do not have positions in the companies mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at www.fool.com/podcasts.

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to www.fool.com/podcasts, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.


Compare Brokers